rdf:type |
|
lifeskim:mentions |
umls-concept:C0005682,
umls-concept:C0027651,
umls-concept:C0072108,
umls-concept:C0079419,
umls-concept:C0205124,
umls-concept:C0205281,
umls-concept:C0220901,
umls-concept:C0237881,
umls-concept:C0376515,
umls-concept:C0449438,
umls-concept:C0521447,
umls-concept:C0750502
|
pubmed:issue |
1
|
pubmed:dateCreated |
1999-4-13
|
pubmed:abstractText |
To evaluate p53 and Bcl-2 expression and proliferating status (PCNA) in subgroups of patients with high-risk superficial and invasive bladder cancer, with relation to cancer progression and death, and to correlate the results with established clinical prognostic factors.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0748-7983
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-5
|
pubmed:dateRevised |
2007-7-2
|
pubmed:meshHeading |
pubmed-meshheading:10188857-Adult,
pubmed-meshheading:10188857-Aged,
pubmed-meshheading:10188857-Aged, 80 and over,
pubmed-meshheading:10188857-Antigens, Neoplasm,
pubmed-meshheading:10188857-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:10188857-Humans,
pubmed-meshheading:10188857-Immunohistochemistry,
pubmed-meshheading:10188857-Middle Aged,
pubmed-meshheading:10188857-Neoplasm Invasiveness,
pubmed-meshheading:10188857-Predictive Value of Tests,
pubmed-meshheading:10188857-Prognosis,
pubmed-meshheading:10188857-Proliferating Cell Nuclear Antigen,
pubmed-meshheading:10188857-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:10188857-Risk,
pubmed-meshheading:10188857-Survival Analysis,
pubmed-meshheading:10188857-Tumor Markers, Biological,
pubmed-meshheading:10188857-Tumor Suppressor Protein p53,
pubmed-meshheading:10188857-Up-Regulation,
pubmed-meshheading:10188857-Urinary Bladder Neoplasms
|
pubmed:year |
1999
|
pubmed:articleTitle |
Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
|
pubmed:affiliation |
Urology Department, Polycliniki Hospital, Athens, Greece.
|
pubmed:publicationType |
Journal Article
|